Read time: 10 minutes
Welcome back to The Ruck Filter.
On 1 October Corteva split into a seed company and a crop-chemicals company, and the stock market had to price the two halves separately. Two weeks later the seed half trades at about 19 times last year’s EBITDA and the chemicals half at under 8. On Thursday FMC, a pure crop-chemicals maker, cut its third-quarter revenue forecast from $840–900 million to $65–125 million and lost 30.5% in a day. In Brussels, EU leaders asked for import safeguards on chemicals and machinery, a week after Beijing accepted a quota on hybrid cars. And the Fed and the ECB decide on consecutive days at the end of the month, the Fed six days before the US midterms, with inflation at 3.7% in the US and 3.8% in the euro area.
Three stories about things the market used to price as one and now prices apart. The first section ends with an instrument idea. The second has none, because the rules it describes are still being written. The third is macro, so it is shorter. After that come the Insider Radar and a short check of last week’s list.
1. Signal vs. Noise: Seeds Get a Premium, Sprays Get Generics 🌱
The Noise: FMC is an American company with too much debt and too much of its product sitting in distributors’ warehouses.
The Alpha: FMC is the extreme case of a price problem that runs through the whole crop-chemicals business: generics, which a US regulator has just made easier to sell. Since the Corteva split, the market prices seeds and crop chemicals separately, and it pays about two and a half times as much for a dollar of seed EBITDA. Bayer earns about half of its crop sales from seeds and trades at the chemicals multiple. BASF is preparing to list an agricultural business that is four-fifths chemicals, with mid-2027 as the target.
The Filter: Corteva shareholders of record on 24 September received one Vylor share for each Corteva share. Vylor holds the seeds, with the Pioneer and Brevant brands. Corteva kept herbicides, insecticides and fungicides (247 Wall St). In 2025 the seed business had sales of $9.9 billion and segment EBITDA of $2.64 billion. Crop protection had $7.5 billion and $1.35 billion (Corteva). On Friday Vylor’s enterprise value of about $51 billion was roughly 19 times its seed EBITDA, the new Corteva’s $10.3 billion about 7.6 times. On expected earnings the gap looks the same: about 26 times against 13 (StockAnalysis).
Three days before the split, on 28 September, the Federal Trade Commission and 12 states settled their case against Corteva. For ten years Corteva may not pay distributors on condition that they buy more than 50% of their needs of an active ingredient from Corteva. According to the FTC, those loyalty payments kept cheaper generics out of the channel after patents expired. The order covers all of Corteva’s off-patent ingredients, and Corteva pays the states $35 million. The case against Syngenta, the Basel-based group owned by China’s Sinochem, continues (FTC).
On Thursday FMC showed how fast the price side can move. In July it had guided to third-quarter revenue of $840 to 900 million and adjusted EBITDA of $120 to 140 million. Now it expects $65 to 125 million of revenue and an EBITDA loss of $510 to 565 million. The difference is mostly $625 to 675 million of “commercial actions”: lower prices on FMC products already sitting with distributors in Brazil, Argentina, the US and Canada. FMC cites “rapid market price declines, driven in part by increased generic competition,” and distributors who want “the lowest inventory levels FMC has experienced.” It will talk to its banks about its covenants, and it plans to narrow the gap between its gross and net prices in the US (SEC filing). The shares lost 30.5% on Thursday. FMC is now worth less than $1 billion.
The same split inside Bayer. Bayer reports both halves of its crop division. In 2025 corn seed grew 13%, while fungicides fell 5% and insecticides 12%, adjusted for currency and portfolio. Corn, soybean, cotton and vegetable seeds brought in €10.6 billion, about half of the division’s €21.6 billion and more than Vylor’s seed business sold. In the first half of 2026, on the same basis, corn seed grew 4.1% and soybean seed 67.9%, while herbicides fell 4.7% and fungicides 7.2%. In its outlook Bayer expects “pressure on prices due to intense competition from suppliers of generic products.” In the second quarter its non-glyphosate herbicides fell mainly on lower prices in North America (half-year report). In March Bayer said the reference price for Chinese generic glyphosate was likely to stay below its 15-year median.
BASF’s timing. BASF’s agricultural business sold €9.6 billion in 2025. Seeds and traits made up €2.0 billion. The rest was fungicides, herbicides, insecticides and seed treatment, and prices fell 1.2% (BASF Report 2025). In September BASF hired Citi, Deutsche Bank, Goldman Sachs and JPMorgan to prepare a Frankfurt listing, with the business to be IPO-ready by mid-2027 (CHEManager). In the first half volumes rose 3.2% and sales fell 1.6%, on prices and currency (Fertilizer Daily). A business that is about four-fifths crop chemicals will come to market against the multiples being set now.
A measured approach:
Sort agricultural exposure by what it sells. About half of Bayer’s crop sales are seeds, about a fifth of BASF’s, none of FMC’s. Since 1 October the market prices those halves differently. What to watch: FMC’s third-quarter results on 29 October and its first expectations for 2027 and 2028 on 30 October, the fullest account yet of how far crop-chemical prices are falling.
Filter Idea: Bayer (BAYN), a seed business at a crop-chemicals price
Thesis: On Friday Bayer was worth €43.7 billion. With €33.6 billion of net financial debt at the end of June, its enterprise value was about €77 billion, or 8 times 2025 EBITDA before special items of €9.67 billion. That is close to the multiple of the new Corteva, which sells only crop chemicals, and well under half of Vylor’s. If I add pensions and the full €11.8 billion of litigation provisions and liabilities Bayer reported in February, the multiple is still below 10. For that price an investor gets a seed business bigger than Vylor’s, a crop-chemicals business bigger than the new Corteva’s, a pharma division with €17.8 billion of sales and consumer health with €5.8 billion. The discount has reasons, and two of them shrank this year. In June the Supreme Court ruled 7 to 2 in Durnell that federal law pre-empts state failure-to-warn claims, which according to Bayer make up the vast majority of Roundup cases. And Bayer has since placed a $5 billion bond and €2 billion of hybrids, and agreed to take €3 billion of equity from Apollo for a minority stake in its long-acting contraceptives unit. The shares are still 12.5% below their close of 28 September. I’d take the seed half at a chemicals price, and I’d use two events to reassess: the third-quarter figures on 3 November, which show seeds and crop protection side by side, and the Missouri court’s still-pending decision on the class settlement.
What would prove me wrong: seed prices that start to follow crop chemicals down, visible first in corn and soybean on 3 November, or a Missouri ruling against the class settlement.
Main risk: nothing forces the market to price the seeds separately. In August Bill Anderson said he wouldn’t allow break-up talk “to be a distraction for us while we’ve got this momentum” (AgNavigator). Without a separation, the seed premium may never reach the share price. The chemicals half faces the same generic pressure FMC described. Bayer expects about €5 billion of litigation payments this year and about €1 billion a year for the following five. A trial that began in St. Louis on 29 September tests design-defect claims that Durnell doesn’t cover. And JPMorgan has warned that early expectations for the third quarter are probably too high because of timing effects in agriculture.
2. Signal vs. Noise: The Fence Moves From Cars to Chemicals and Machinery 🧱
The Noise: The hybrid deal ended the trade fight with China.
The Alpha: The hybrid deal became the template. A week after Beijing accepted a quota, EU leaders asked for the same kind of tool for chemicals and machinery, two of Germany’s largest export industries. The tool counts where a product is made, not who owns the plant, and it applies to imports from every country. That puts German companies on both sides of the line, and Swiss exporters outside it if steel is the precedent.
The Filter: China’s exports rose 36.3% in September from a year earlier. Its trade surplus was $133.5 billion for the month and $938 billion for the first nine months (AP). The EU runs a deficit of about €360 billion a year with China (Euronews).
The hybrid deal now has numbers. Bloomberg reports a quota of 350,000 Chinese hybrids and plug-in hybrids for the first 12 months, rising 6% a year over four years, from as early as 1 December (via autoevolution). Chinese hybrid imports are on course for about 800,000 this year, against 300,000 in 2025. Legally the quota is a WTO safeguard, so it covers hybrid imports from every source, and Chinese-brand cars built inside the EU are exempt (Automotive World). Trade commissioner Maroš Šefčovič called the deal a “blueprint” (EUobserver).
At their summit on Thursday and Friday, EU leaders asked the Commission to “prepare a toolbox of new trade defence instruments, including safeguards with quotas and tariffs,” and singled out chemicals and machinery (Euronews). Officials said leaders want safeguards “without delay.” Friedrich Merz: “We will create instruments against leveraging capacities, against high subsidies, against undervalued currencies.” A safeguard needs no proof of dumping or subsidies, only an import surge that seriously harms European producers. It must apply to all countries and can last at most eight years (EUobserver). By the end of the year the Commission also wants a diversification tool and a mechanism to compensate companies hit by Chinese countermeasures.
The Franco-German paper of 5 October shows where Berlin and Paris want to take this. It names chemicals, PET and plug-in hybrids as urgent cases and proposes safeguards “while minimizing negative consequences of its erga omnes effect.” It wants a new instrument, “adopted unless a qualified majority is opposed,” that could regulate “access to the single market.” On currencies it says “a nominal appreciation could help rebalance trade.” And it asks for “an inventory of retaliation measures.”
Who is inside. The car rules show how the line gets drawn. On Thursday Paris and Berlin agreed that “made in Europe” rules for publicly supported car production should cover the EU and close partners such as the UK and Norway, but not Morocco or Turkey. No local-content level has been published (AFP, via Journal de l’Automobile). In machinery, China overtook Germany in 2025 as the world’s largest exporter of machine tools, €8.6 billion against €7.0 billion, and German domestic orders fell 16%. The twelve larger German makers that produce abroad make 32% of that output in China, under what the industry association VDW calls local for local.
Who is outside. Switzerland, on the steel record. In 2019 the EU exempted Norway, Iceland and Liechtenstein from its steel safeguard, but not Switzerland (swissinfo). The measure that replaced the safeguard on 1 July 2026, with duty-free quotas cut by about half and a 50% duty above them, also applies to Switzerland, with country quotas in some categories (Switzerland Global Enterprise).
The equity read. The fence has reached two more industries where German exposure runs both ways. BASF is the clearest case. Ludwigshafen sits inside the European fence. Its Zhanjiang Verbund site, an investment of about €8.7 billion and the largest in BASF’s history, was built to serve customers in China and the rest of Asia. Beijing opened an anti-dumping probe into EU p-nitrotoluene, an intermediate for dyes, rubber chemicals and some pesticides, on 3 October. Since 2025 the EU has opened 28 trade-remedy investigations into Chinese goods, about half of them in chemicals (Global Agriculture). The investment case for a European chemical or machinery stock now includes a question that used to belong to customs lawyers: where are the plants that serve the European customer?
A measured approach:
Screen chemical and machinery holdings by plant address, not head office. EU plants selling into the EU are inside. Plants in China, the US or Switzerland shipping into the EU may not be, and companies selling into China carry the retaliation risk that Brussels already plans to compensate. What to watch: the Commission’s proposals, whether Switzerland is treated as it was in steel, Beijing’s answer, and 10 November.
3. Signal vs. Noise: Two Central Banks, Two Days, One Election 🗳️
The Noise: The only rate question is what Kevin Warsh does.
The Alpha: The Fed decides on 28 October and the ECB on 29 October. Inflation is above 3.5% on both sides of the Atlantic, and on both sides energy is driving it. Euro-area inflation is now higher than America’s. Germany’s bond auctions show where the strain sits: three in a row at maturities of two to seven years drew bids below the amount on offer, while 21- and 30-year Bunds cleared.
The Filter: US consumer prices rose 3.7% in September from a year earlier (expected 3.6%), with gasoline up 9.1% in the month. Core inflation was 2.6% (investingLive). Producer prices rose 1.3% in the month, the most since March 2022, and goods prices 2.6%, the largest increase since the series began in 2009 (BLS). After the CPI, futures priced a 41.5% chance of a hike on 28 October, up from 22.1% (CME FedWatch, via 247 Wall St). The midterms are on 3 November. The last time the Fed raised rates within a week of an election was 2 November 2022, by 75 basis points, six days before that year’s midterms. In a note before the CPI, UBS called an October hike on the eve of the midterms “politically untenable.” Warsh’s speech on Friday didn’t address policy, and hike bets eased (dpa-AFX). The ten-year Treasury yield fell over the week from 5.24% to 5.09% (US Treasury).
Euro-area inflation was 3.8% in September, against 3.6% expected, with energy up 18.8% (Eurostat flash estimate, via Option Finance). The ECB raised rates in June and again in September, taking the deposit rate to 2.50%. Markets now lean towards a December move, with October still possible (Trading Economics).
The Bund auctions. On 6 October the Finance Agency offered €6 billion of two-year Schatz and received bids for €4.87 billion, at 3.10%. On 7 October it offered €4 billion of a 2033 Bund and drew bids for €2.72 billion. On 13 October it offered €5 billion of five-year Bobl, received €3.61 billion of bids and kept €1.65 billion on its own books, at 3.22%. On 14 October the 2047 Bund drew €2.80 billion of bids for €1.5 billion on offer, and the 2056 Bund €1.06 billion for €1 billion, both at 3.80% (Bundesbank). Retention is routine, and the retained bonds are sold into the market later. But the shortfalls sit in the maturities closest to ECB policy.
The equity read. This is macro, so I’ll keep it short. When central banks raise rates into an energy shock, debt gets more expensive just as margins come under pressure. For most German borrowers that price is set in the two- to seven-year part of the curve. Bayer, the idea in section 1, shows the level: on 23 September it placed €2 billion of hybrid bonds with coupons of 5.75% and 6.25% and non-call periods of six and nine years. That is part of the cost of capital behind its discount, set in the same maturities where the auctions fell short.
A measured approach:
Treat 28 and 29 October as one event, in the middle of earnings season. BASF reports on the morning of 28 October, the Fed decides that evening, the ECB follows on 29 October, FMC on 29 and 30 October, and Bayer on 3 November, the day of the midterms. What to watch: whether the next two- to seven-year auctions fall short again after the ECB has spoken.
🔎 Insider Radar
Under the EU’s market abuse rules, managers report their own trades within three business days. The filings show where management puts its own money. They don’t say why, and a purchase isn’t a forecast. This box reports; it doesn’t recommend.
Krones. Schawei GmbH, closely associated with supervisory board member Petra Schadeberg-Herrmann, bought 5,200 shares for €546,086, at €105.02, outside a trading venue on 12 October. The filing came out on Thursday. The same company sold Krones shares for about €598,000 at €142.35 in January and bought about €985,000 worth at €109.50 in April 2025.
MBB. MBB Capital Management, closely associated with Christof Nesemeier, chairman of the board of directors and managing director, bought shares on Xetra for €167,390 at €167.39 on 8 October and for €129,777 at €173.04 on 9 October. Together that is about €297,000. Both filings were published on Monday.
🔁 Last Week’s Watch List
⏳ Telekom. T-Mobile recovered 7.1% to $159.10 by Friday’s close, Telekom about 5%. That is close to what the stake arithmetic in #040 implied, about 0.65 times the move in T-Mobile before currency. Raymond James upgraded T-Mobile to outperform with a $170 target, arguing that the SpaceX fears are overdone. Bernstein cut its target from $220 to $180. I haven’t found any petitions against the Grain transfer at the FCC so far. T-Mobile reports on 28 October, Telekom on 5 November.
⚠️ China avoid list. BMW’s China deliveries fell 24.8% in the third quarter and 21.8% over nine months, and group deliveries fell 6.3% (electrive). The main risk I named last week, Europe, also showed up: on Friday carmakers gained up to 3.5% after the Franco-German car agreement (dpa-AFX). The list runs to 10 November.
⚠️ 10 November. In #040 I wrote that no extension had been announced. That still holds for the suspended rare-earth controls. I should have added that on 28 September Beijing and Washington extended their wider trade arrangement to 10 January 2027. China’s commerce ministry didn’t say whether the rare-earth suspension is part of that (Global Times, FXStreet).
✅ Rocket Lab. In #020 I named a second tank problem pushing Neutron into 2027 as the risk to watch. On Wednesday Rocket Lab moved the first flight to 2027, citing a manufacturing defect in the forward dome of the first-stage tank. The shares fell 7.85% in regular trading and another 7.4% after hours (Finviz).
Outro: Priced Apart
Until 30 September Corteva’s seeds and sprays had one share price. Now they have two, and the market pays about two and a half times as much for a dollar of seed EBITDA. Brussels is drawing its new fence by plant address. The German bond market bids more than the amount on offer for 21- and 30-year Bunds and leaves two- to seven-year paper on the Finance Agency’s books.
Bayer shows seeds and crop chemicals separately in every quarterly report. The share price doesn’t. Either the litigation, the debt and the chemicals half outweigh a seed business larger than Vylor’s, or that seed business is priced like crop chemicals. The third-quarter report on 3 November is the first chance to check.
The Takeaway: Which of your holdings owns a business the market would value higher on its own, and what would make the market look?
Daniel Ruck Editor, The Ruck Filter
Filter Sources this week
247 Wall St — Corteva split into Vylor and Corteva, October 2, 2026
Corteva — full-year 2025 results, segment sales and operating EBITDA
StockAnalysis — Vylor, Corteva, FMC and T-Mobile US prices, enterprise values and forward P/E ratios, October 15–16, 2026; Bayer price, market value and shares outstanding, October 16, 2026
Federal Trade Commission — settlement with Corteva, September 28, 2026
SEC — FMC Form 8-K, October 15, 2026; FMC second-quarter 2026 results and outlook
Bayer — full-year 2025 results and presentation, March 4, 2026; investor and media update on litigation provisions, February 17, 2026; half-year financial report Q2 2026; Q2 2026 results, August 4, 2026; statement on the Durnell decision, June 25, 2026; litigation statements on the class settlement, August–September 2026; hybrid bond placement, September 23, 2026
Börse Express — Bayer’s $5 billion bond, July 2026
Pharmaphorum — Apollo’s €3 billion equity investment in Bayer’s long-acting contraceptives unit, July 10, 2026
AgNavigator — Bill Anderson on break-up speculation, August 4, 2026
Global Agriculture — Missouri Roundup trial and pending settlement ruling, October 3, 2026; China’s p-nitrotoluene probe and EU trade-remedy count, October 5, 2026
Kapitalmarktexperten — JPMorgan on Bayer’s third quarter, Q3 date, October 12–13, 2026
Münster Aktuell — Bayer share price, September 28 – October 8, 2026
BASF Report 2025 — Agricultural Solutions; BASF financial calendar, third-quarter results, October 28, 2026
CHEManager — BASF Agricultural Solutions IPO preparation, September 16, 2026
Fertilizer Daily — BASF Agricultural Solutions first half 2026, July 30, 2026
AP (via NY1 and CP24) — China’s September trade data, October 14, 2026
Euronews — takeaways from the EU leaders’ summit, October 16, 2026
EUobserver — EU open to curbs on Chinese chemicals and machinery, October 15, 2026
Franco-German non-paper on European resilience (published by Le Grand Continent), October 5, 2026
autoevolution (citing Bloomberg) — hybrid quota, October 12, 2026
Automotive World — hybrid quota details and import figures, October 12–13, 2026
Journal de l’Automobile (AFP) — Franco-German agreement on the car package, October 15, 2026
VDW — annual press conference, January 19, 2026; machine tool production and exports, March 18, 2026
swissinfo — no Swiss exemption from the EU steel safeguard, February 1, 2019
Switzerland Global Enterprise — new EU and UK steel measures from July 1, 2026
BASF — first products at the Zhanjiang Verbund site, November 5, 2025
investingLive — US September CPI, October 14, 2026
US Bureau of Labor Statistics — Producer Price Index, September 2026, October 15, 2026
247 Wall St — CME FedWatch, 2022 precedent and UBS note, October 15, 2026
finanzen.at (dpa-AFX) — Frankfurt close and Warsh speech, October 16, 2026
US Department of the Treasury — daily par yield curve rates, October 2026
Option Finance — euro area flash inflation, September 2026, October 2, 2026
FN News — ECB rate decision, September 10, 2026
Trading Economics — German bond yields and ECB expectations, October 15–16, 2026
Deutsche Bundesbank — auction results, October 6, 7, 13 and 14, 2026
EQS-DD — Krones (Schawei GmbH), October 15, 2026, January 19, 2026 and April 9, 2025; MBB (MBB Capital Management), October 12, 2026
Börse Express — Deutsche Telekom share price, October 16, 2026
Goldesel — Raymond James and Bernstein on T-Mobile US, October 14, 2026
electrive — BMW third-quarter deliveries, October 13, 2026
Global Times — China–US arrangement extended to January 10, 2027, September 28, 2026
FXStreet — rare-earth suspension and November 10, October 14, 2026
Finviz — Rocket Lab delays Neutron to 2027, October 15, 2026
Disclaimer: The Ruck Filter is for informational purposes only and does not constitute financial, investment, or tax advice. The information provided is based on data available at the time of writing and is subject to change. Investing in financial markets involves risks, including the potential loss of principal. Every reader is solely responsible for their own trading and investment decisions. Please conduct your own due diligence or consult with a licensed professional before making any financial commitments. Companies with potential conflicts of interest are excluded from coverage as a matter of editorial policy.